SLC30A5 and type 2 diabetes mellitus: Lastly, ZnT5 has also been associated with various pathological phenotypes in humans, including an increase in inflammatory markers [274], obesity [275,276], type 2 diabetes mellitus (T2D) [277], colorectal cancer [278] and AD [279].